We integrate heterogeneous molecular data of 11,289 tumors and 1,001 cell lines
We measure the response of 1,001 cancer cell lines to 265 anti-cancer drugs
We uncover numerous oncogenic aberrations that sensitize to an anti-cancer drug
Our study forms a resource to identify therapeutic options for cancer sub-populations